Expertise

It's at the heart of everything we do

e.g. asthma, appendicitis, Wright, Peter Kroll

EvidenceCare offers healthcare providers complete access to content curated by some of the industry’s foremost experts. We continue to develop content to meet the needs of our customers.

Pneumonia

CME: Up to 6 Launch Protocol
The EvidenceCare Pneumonia pathway allows the provider to determine the optimal treatment protocol for a patient with suspected Pneumonia. The protocol is broken down into management of patients with Community-Acquired (CAP), Hospital-Acquired (HAP), and Ventilator-Associated Pneumonia (VAP). In Community-Acquired Pneumonia patients the user is guided through risk stratification of the patient's clinical severity using the CURB-65, the Pneumonia Severity Index (PSI), or clinical gestalt. Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) consideration of whether the patient has any MRSA or Pseudomonas risk factors are taken into account to determine the optimal antibiotic regimen. Guidelines that are used in this pathway include the new 2016 IDSA HAP/VAP Guidelines, the NICE Guidelines for Pneumonia, and the IDSA/ATS Community-Acquired Pneumonia Guidelines.
Read More

Pulmonary Embolism (PE)

Jeffrey Kline, MD

Pulmonary Embolism

CME: Up to 6 Launch Protocol
The diagnostic workup and proper treatment approach to patients with pulmonary embolism can be challenging. The EvidenceCare Pulmonary Embolism pathway includes a diagnostic algorithm using the Wells Score and PERC rule as well as workup of the pregnant patient. For patients positive for pulmonary embolism we help the provider risk stratify their patient including whether they have intermediate (submassive) or massive clot burden. From there we help the provider go through appropriate anticoagulation options, indications and contraindications to fibrinolytic therapy. Indications for catheter-directed fibrinolysis, ECMO, and rescue embolectomy are also discussed.
Read More

Seizures

CME: Up to 3 Launch Protocol
The EvidenceCare Seizure pathway provides treatment guidelines for management of seizures in the hospital setting and includes recommendations for new onset seizures, alcohol withdrawal seizures, and recurrent seizures in both adults and pediatric patients. Treatment recommendations address emergent initial treatment, urgent control therapy and treatment of refractory status epilepticus. Recommendations are based on the latest research and guidelines from the American College of Emergency Physicians and Neurocritical Care Society (NCS).
Read More

Sepsis

CME: Up to 2 Launch Protocol
Sepsis kills over 258,000 each year and is one of the most costly conditions in our healthcare system. The EvidenceCare Sepsis pathway provides treatment recommendations based on whether the patient has Sepsis, Severe Sepsis, or is in Septic Shock. We help providers determine when to utilize qSOFA, SOFA, and ultrasound-guided fluid resuscitation. These recommendations are base on the 2015 updated Surviving Sepsis Campaign guidelines, the recently released Sepsis-3 guidelines, and data from the ProCESS, ARISE, and PROMISE trials.
Read More

Small Bowel Bleeding

Jonathan Leighton, MD

Small Bowel Bleeding

Bleeding from the small intestine remains a relatively uncommon event, accounting for ~5–10% of all patients presenting with gastrointestinal (GI) bleeding. Given advances in small bowel imaging with video capsule endoscopy (VCE), deep enteroscopy, and radiographic imaging, the cause of bleeding in the small bowel can now be identified in most patients. A source of small bowel bleeding should be considered in patients with GI bleeding after performance of a normal upper and lower endoscopic examination. Second-look examinations using upper endoscopy, push enteroscopy, and/or colonoscopy can be performed if indicated before small bowel evaluation. VCE should be considered a first-line procedure for small bowel investigation. Any method of deep enteroscopy can be used when endoscopic evaluation and therapy are required.…
Read More

Stroke (Acute Ischemic)

CME: Up to 6 Launch Protocol
Stroke is the leading cause of disability in the United States. The EvidenceCare Stroke pathway consolidates information essential for providers evaluating patients with concern for cerebrovascular accidents (Strokes). Outlined are the recommendations for fibrinolytic therapy in acute ischemic stroke, including data from the 2015 AHA Advisory statement regarding changes to the inclusion and exclusion criteria for administration of tPA. The pathway highlights new endovascular interventional approaches in Acute Ischemic Stroke. Information is based off of the 2013 American Heart Association (AHA) Acute Ischemic Stroke Guidelines and the 2015 updated AHA recommendations for Endovascular intervention, and the 2014 AHA Guidelines for the Prevention of Stroke in patients with Stroke and Transient Ischemic Attack.
Read More

Transient Ischemic Attack (TIA)

William Brady, MD

Acute Coronary Syndrome (ACS)

CME: Up to 2 Launch Protocol
Stroke is the leading cause of disability in the United States. The EvidenceCare Stroke TIA protocol consolidates information essential for providers evaluating patients with concern for transient ischemic attacks (TIAs). Information is based off of the 2013 American Heart Association (AHA) Acute Ischemic Stroke Guidelines and the 2014 AHA Guidelines for the Prevention of Stroke in patients with Stroke and Transient Ischemic Attack.
Read More